Detalles de la búsqueda
1.
Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain.
Int J Mol Sci
; 20(4)2019 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30769782
2.
Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis.
Eur J Med Chem
; 224: 113666, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245949
3.
Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain.
J Oral Facial Pain Headache
; 29(3): 286-96, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26244437
4.
A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Arthritis Rheum
; 60(7): 2008-18, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19565489
5.
Novel magnetic supports for small molecule affinity capture of proteins for use in proteomics.
Mol Divers
; 8(1): 9-19, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-14964784
Resultados
1 -
5
de 5
1
Próxima >
>>